KR20230116864A - Lca 및 3-kca를 udca 및 3-kudca로 전환하기 위한 효소적방법 - Google Patents

Lca 및 3-kca를 udca 및 3-kudca로 전환하기 위한 효소적방법 Download PDF

Info

Publication number
KR20230116864A
KR20230116864A KR1020237021971A KR20237021971A KR20230116864A KR 20230116864 A KR20230116864 A KR 20230116864A KR 1020237021971 A KR1020237021971 A KR 1020237021971A KR 20237021971 A KR20237021971 A KR 20237021971A KR 20230116864 A KR20230116864 A KR 20230116864A
Authority
KR
South Korea
Prior art keywords
seq
leu
ala
gly
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237021971A
Other languages
English (en)
Korean (ko)
Inventor
제이. 조지 레이드
자야찬드란 피. 레디
베른하르트 제이. 폴
우슐라 스켈
매트 그레고리
Original Assignee
샌드힐 원, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 샌드힐 원, 엘엘씨 filed Critical 샌드힐 원, 엘엘씨
Publication of KR20230116864A publication Critical patent/KR20230116864A/ko
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/06Hydroxylating
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C12N9/0038Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6) with a heme protein as acceptor (1.6.2)
    • C12N9/0042NADPH-cytochrome P450 reductase (1.6.2.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/84Pichia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/85Saccharomyces
    • C12R2001/865Saccharomyces cerevisiae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y106/00Oxidoreductases acting on NADH or NADPH (1.6)
    • C12Y106/02Oxidoreductases acting on NADH or NADPH (1.6) with a heme protein as acceptor (1.6.2)
    • C12Y106/02004NADPH-hemoprotein reductase (1.6.2.4), i.e. NADP-cytochrome P450-reductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/14Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen (1.14.14)
    • C12Y114/14001Unspecific monooxygenase (1.14.14.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
KR1020237021971A 2020-11-30 2021-11-29 Lca 및 3-kca를 udca 및 3-kudca로 전환하기 위한 효소적방법 Pending KR20230116864A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063119188P 2020-11-30 2020-11-30
US63/119,188 2020-11-30
PCT/US2021/061025 WO2022115710A1 (en) 2020-11-30 2021-11-29 Enzymatic methods for converting lca and 3-kca to udca and 3-kudca

Publications (1)

Publication Number Publication Date
KR20230116864A true KR20230116864A (ko) 2023-08-04

Family

ID=81754944

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237021971A Pending KR20230116864A (ko) 2020-11-30 2021-11-29 Lca 및 3-kca를 udca 및 3-kudca로 전환하기 위한 효소적방법

Country Status (8)

Country Link
US (1) US20230416800A1 (https=)
EP (1) EP4251169A4 (https=)
JP (1) JP2023552528A (https=)
KR (1) KR20230116864A (https=)
CN (1) CN116670147A (https=)
AU (1) AU2021385425A1 (https=)
CA (1) CA3201311A1 (https=)
WO (1) WO2022115710A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4665352A2 (en) * 2023-02-14 2025-12-24 Epimeron USA, Inc. Recombinant polypeptides for biosynthesis of ursodeoxycholic acid (udca)
CN117025709A (zh) * 2023-07-31 2023-11-10 华南理工大学 一种细胞色素p450酶联合细胞色素p450还原酶在合成熊去氧胆酸中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58155098A (ja) * 1982-03-09 1983-09-14 Yakult Honsha Co Ltd 微生物によるウルソデオキシコ−ル酸の製造法
US5989855A (en) * 1996-03-29 1999-11-23 Tokyo Tanabe Company Limited Bile acid converting microorganism and process for preparing bile acid
WO2013086499A2 (en) * 2011-12-09 2013-06-13 Ceres, Inc. Transgenic plants having altered biomass composition
EP3444340B1 (de) * 2014-07-29 2020-04-15 Pharmazell GmbH 7beta-hydroxysteroid dehydrogenase-mutanten und verfahren zur herstellung von ursodesoxycholsäure
IT201900017411A1 (it) * 2019-09-27 2021-03-27 Ice S P A Processo di preparazione di acido ursodesossicolico

Also Published As

Publication number Publication date
CA3201311A1 (en) 2022-06-02
CN116670147A (zh) 2023-08-29
US20230416800A1 (en) 2023-12-28
JP2023552528A (ja) 2023-12-18
AU2021385425A9 (en) 2025-01-09
WO2022115710A1 (en) 2022-06-02
EP4251169A1 (en) 2023-10-04
AU2021385425A1 (en) 2023-06-15
EP4251169A4 (en) 2025-07-09

Similar Documents

Publication Publication Date Title
AU2021203937B2 (en) Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves
KR102863167B1 (ko) 클로스트리듐 박테리아의 형질전환을 위한 유전자 도구
AU2020205228B2 (en) Gene therapies for lysosomal disorders
KR101850162B1 (ko) 형질전환용 플라스미드
KR100820367B1 (ko) 피히아 파스토리스에서의 단백질 글리코실화 변형
CN112546211A (zh) 基于mRNA的针对冠状病毒和流感病毒的联合疫苗及其制备方法
KR101047167B1 (ko) 피치아 파스토리스에서의 단백질 글라이코실화 변형
CN112888426A (zh) Aav三质粒系统
CN107630029B (zh) 一种产朊假丝酵母游离型表达载体及其构建方法与应用
DK2931918T5 (en) PROCEDURE FOR IDENTIFYING A CELL WITH INCREASED CONCENTRATION OF A PARTICULAR METABOLIT COMPARED TO THE SIMILAR WILD TYPE CELL .....
KR102931179B1 (ko) 선형 재조합 dna 작제물 및 이의 조성물을 이용하여 공여 dna 서열을 바실러스 게놈 내에 통합시키기 위한 방법
CN109996874A (zh) 10-甲基硬脂酸的异源性产生
KR20230116864A (ko) Lca 및 3-kca를 udca 및 3-kudca로 전환하기 위한 효소적방법
KR20210148270A (ko) 이중 원형 재조합 dna 작제물 및 이의 조성물을 이용하여 바실러스의 게놈 내로의 폴리뉴클레오타이드를 통합하기 위한 방법
AU2017252409B2 (en) Compositions and methods for nucleic acid expression and protein secretion in bacteroides
CN113584074B (zh) 假重组嵌合黄瓜花叶病毒介导的基因沉默系统及其应用
CN112553240A (zh) 重组表达载体系统、重组工程菌及其制备方法和用途
CN115074304B (zh) 一种谷氨酸棒杆菌突变体及重组菌构建方法与应用
KR20220041928A (ko) 바실러스 리체니포르미스에서 단백질 생산을 증가시키기 위한 조성물 및 방법
RU2731513C2 (ru) Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов NOS2, NOS3, VIP, KCNMA1, CGRP, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-NOS2, или Escherichia coli SCS110-AF/VTvaf17-NOS3, или Escherichia coli SCS110-AF/VTvaf17-VIP, или Escherichia coli SCS110-AF/VTvaf17-KCNMA1, или Escherichia coli SCS110-AF/VTvaf17-CGRP, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
KR20170068304A (ko) 대장균 및 코마가타에이박터 속 세포에서 복제가능한 벡터, 그를 포함한 세포, 및 그를 이용하는 방법
CN116615550A (zh) 细菌微区室病毒样颗粒
CN116547263A (zh) 用修饰酶产生取代大麻素和前体的方法和细胞
CN115243701A (zh) 用于无佐剂诱导免疫应答的IgG变体
HK40082516A (en) Igg variants for induction of immune response without adjuvant

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902